MONCTON, New Brunswick — As an early investor in biosynthesis, Organigram Holdings Inc. (NASDAQ: OGI), (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, and Hyasynth Biologicals Inc. (“Hyasynth”) a private biotechnology company and pioneer in the field of cannabinoid science…

From sleep-inducing gummy bears to pain-relieving drops and topical creams for anxious pets, you’ve probably heard of the new big thing in health and wellness: CBD, or cannabidiol. CBD is popular among consumers of many demographics and is touted by many as a safe and natural remedy for a long…

With growing interest in the health and wellness sectors, consumers around the world are increasing the demand for natural products. The pharmaceutical industry is getting on the bandwagon too, with more and more research being dedicated to exploring medical uses of natural compounds such as cannabinoids. Traditionally, these natural products…

MONTREAL, QUEBEC, CANADA, May 26, 2021 / EINPresswire.com/ — Hyasynth, a sustainable biotechnology company specializing in fermentation-produced cannabinoid ingredients, today announced an update on its biosynthesis process and patent portfolio. On April 13, 2021 the company received a grant on US patent no 10,975,395 covering the use of its novel…

Hyasynth receives $2.5 million milestone payment following first-to-market achievement with CBD produced by fermentation MONTREAL, Oct. 23, 2020 /CNW Telbec/ — Hyasynth, a sustainable biotechnology company, has received a $2.5M milestone payment for its commercialization achievements in being first-to-market with cannabidiol (CBD) produced and extracted from yeast. The additional investment…

MONTREAL, Sept. 28, 2020 /CNW Telbec/ — Hyasynth, a sustainable biotechnology company, takes top spot from global competitors by making the first ever sale of cannabidiol (CBD) produced and extracted from yeast. Hyasynth produces CBD through a yeast fermentation process, without the need for traditional cultivation and extraction from cannabis…

Montreal — QC — 2020–09–10 Hyasynth, a Canadian biotechnology company specializing in sustainable cannabinoid ingredients through biosynthesis, today announced the appointment of Nitin Kaushal, CPA, CA as Executive Chairman. Mr. Kaushal will assist Hyasynth’s management in corporate development, growth, and partnership strategies. Mr. Kaushal brings over 30 years of finance…

People first… (as usual) Summer has been wonderful and busy. We grew our team even more with a collection of smart and agile summer students that adapted quickly to their new jobs. Thanks for being awesome!

It has been VERY long time since we have done anything on social media, and I figure that now is as good a time as ever to talk about our progress. Fluffy stuff will come at the end. People first… We are 17 staff now and have added a few more advisors…